MSRPS
REGN icon

Maryland State Retirement & Pension System’s Regeneron Pharmaceuticals REGN Stock Holding History

Maryland State Retirement & Pension System’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44M Buy
5,518
+428
+8% +$291K 0.06% 260
2026
Q1 		$3.93M Buy
5,090
+61
+1% +$46.7K 0.08% 202
2025
Q4 		$3.88M Sell
5,029
-120
-2% -$81.5K 0.08% 203
2025
Q3 		$2.9M Buy
5,149
+80
+2% +$45.2K 0.06% 254
2025
Q2 		$2.66M Buy
5,069
+182
+4% +$102K 0.06% 261
2025
Q1 		$3.1M Sell
4,887
-806
-14% -$554K 0.07% 215
2024
Q4 		$4.06M Sell
5,693
-334
-6% -$280K 0.09% 182
2024
Q3 		$6.34M Sell
6,027
-2,119
-26% -$2.36M 0.13% 132
2024
Q2 		$8.56M Buy
8,146
+98
+1% +$95K 0.16% 116
2024
Q1 		$7.31M Buy
8,048
+68
+0.9% +$64.7K 0.15% 128
2023
Q4 		$7.01M Hold
7,980
– – 0.14% 130
2023
Q3 		$6.57M Buy
7,980
+65
+0.8% +$51.1K 0.15% 125
2023
Q2 		$5.69M Sell
7,915
-291
-4% -$224K 0.12% 144
2023
Q1 		$6.74M Buy
8,206
+49
+0.6% +$37K 0.15% 120
2022
Q4 		$5.89M Buy
+8,157
New +$6.02M 0.17% 123
2022
Q3 		– Sell
-7,986
Closed -$4.72M – 1097
2022
Q2 		$4.72M Buy
7,986
+77
+1% +$50.1K 0.15% 116
2022
Q1 		$5.52M Buy
7,909
+265
+3% +$168K 0.15% 111
2021
Q4 		$4.83M Hold
7,644
– – 0.13% 134
2021
Q3 		$4.68M Buy
7,644
+149
+2% +$92.5K 0.13% 128
2021
Q2 		$4.36M Buy
7,495
+83
+1% +$42K 0.14% 137
2021
Q1 		$3.51M Buy
7,412
+5,844
+373% +$2.85M 0.12% 156
2020
Q4 		$805K Buy
+1,568
New +$846K 0.15% 141

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Maryland State Retirement & Pension System's REGN Position: Q2 2026 in Review

Maryland State Retirement & Pension System increased its Regeneron Pharmaceuticals (REGN) stake by 8.4% in Q2 2026, buying an estimated $291K and bringing the position to 5,518 shares worth $3.44M. The position accounts for 0.06% of the portfolio, ranked #260.

Maryland State Retirement & Pension System first reported a position in REGN in Q4 2020 and has held it in 22 quarters since. The position peaked at $8.56M in Q2 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Maryland State Retirement & Pension System held 5,518 shares of Regeneron Pharmaceuticals worth $3.44M as of Q2 2026.
  • Maryland State Retirement & Pension System bought 428 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $291K.
  • Regeneron Pharmaceuticals made up 0.06% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #260 holding.
  • Maryland State Retirement & Pension System first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Maryland State Retirement & Pension System's Regeneron Pharmaceuticals position peaked at $8.56M in Q2 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.